Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Atorvastatin to decrease intensity of clinical manifestations in patients with COVID-19
IRCT20201028049175N3Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of atorvastatin in coronavirus disease 2019 (COVID-19), sponsored by Arak University of Medical Sciences. Started Feb 2021; status: completed.
02
Drugs
atorvastatin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20201028049175N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201028049175N3.